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Human papillomavirus (HPV) infection is threefold more prevalent in spontaneous abortion specimens compared to
elective abortions, preferentially targeting the placental trophoblasts in these specimens. Here, by using infectious center
and Southern blot analysis, we demonstrate that the transfected HPV-16 genome de novo replicates in 3A trophoblasts in
culture. Peak DNA replication occurred 9–24 days posttransfection, showing classic DNA forms I, II, and III and an 8-kb
monomer band upon DpnI/BamHI digestion. Reverse transcription-polymerase chain reaction (RT-PCR) analysis of mRNA
expression revealed that E6 and E2 were significantly expressed by day 9, coinciding with HPV-16 DNA replication. However,
significant L1 expression was delayed until day 18. L1 protein expression on day 18, but not day 9, was also confirmed by
Western blot analysis. The production of HPV-16 virions was demonstrated by three techniques: the appearance of HPV-16
infectious units coinciding with L1 expression, the neutralization of these infectious units with known neutralizing anti-HPV-16
antibodies, and the appearance of spliced E1‘E4 and E6‘E7 transcripts (RT-PCR) in normal keratinocyte rafts infected with
these trophoblast-produced HPV-16 infectious units. These data suggest that HPV-16 is carrying out its complete life cycle
in trophoblasts. Previously, HPVs were known to productively replicate only in differentiating keratinocytes of skin. These
findings expand HPV biology, support the hypothesis of a possible link between HPV and some spontaneous abortions, and





















There are a number of studies that suggest that hu-
man papillomavirus (HPV) infection may be linked with
spontaneous abortions or commonly infect placental ma-
terial (Armbruster-Moraes et al., 1994; Favre et al., 1998;
ermonat et al., 1997, 1998; Malhomme et al., 1997;
anavi et al., 1992; Pao et al., 1995; Rabreau and Saurel,
997; Sikstrom et al., 1995). For example, in earlier stud-
es our laboratory found that HPV infection is threefold
ore prevalent in spontaneous aborted products of con-
eption compared to elective abortions (60% vs 20%) and
hat the HPVs were preferentially infecting the tropho-
lasts within the placenta (Hermonat et al., 1997, 1998).
alhomme et al. (1997) have also found that 70% of
pontaneous abortion specimens contain HPV by poly-
erase chain reaction (PCR) analysis. In addition, Sik-
trom et al. (1995) found that women with a history of
PV infection had a higher risk of spontaneous abortion
odds ratio of 3). Pao et al. (1995) found that HPV-18 was
resent in 50% of choriocarcinomas (malignant tropho-
lasts) and in some placentas. Also related to this issue,
PV DNA has been detected by PCR amplification of3
t
1 To whom correspondence and reprint requests should be ad-
ressed. E-mail: hermonatpaull@uams.edu.
99NA from cells taken from amniotic fluids of pregnant
omen with evidence of HPV genital (60% HPV positive)
r cutaneous infection, indicating that HPV has the ca-
acity to cross the placental barrier when present in the
ervix (Armbruster-Moraes et al., 1994; Favre et al., 1998).
owever, others do not see HPV in spontaneous abor-
ion materials or in normal placentas (Genest et al., 1999;
ppel et al., 2000).
Trophoblasts are the cells of the placenta that are in
irect contact with the maternal tissues. These cells are
ritical for anchoring the placenta to the maternal tis-
ues. Furthermore, all nutrient exchange and waste ex-
hange occur through the trophoblasts. Thus, the disrup-
ion of the trophoblastic layer, by HPV or any other
nfectious or chemical agent, could likely result in abnor-
al plantation or expulsion of the gestation (Clark et al.,
993).
RESULTS
ong-term HPV-16 DNA replication in 3A trophoblasts
The finding that HPVs are present in trophoblasts
rompted the analysis of HPV type 16 (a common genital
PV) biological activity in this newly identified target cell
ype. We chose to study HPV-16 biological activity in the
A trophoblast cell line, which has been altered to con-
ain a temperature-sensitive SV40 large T antigen. These
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100 LIU ET AL.cells have a normal, nontransformed phenotype at 39.5–
40°C, are mortal, and have normal trophoblast traits
[e.g., synthesize human chorionic gondotropin (HCG)
and alkaline phosphatase] (Chou, 1978). For all of our
experiments the 3A cells were maintained at 39.5–40°C.
Under these conditions we found that our 3A cells se-
creted HCG by enzyme-linked immunosorbant assay
(ELISA) (data not shown). Our 3A cultures were able to
actively divide at 39.5–40°C and were heterogeneous in
nature, containing both cytotrophoblasts (small precur-
sor cells) and syncytiotrophoblasts (large, mature,
multinucleated cells). We first observed whether HPV-16
might replicate in these cells using the infectious center
assay, which is intended to identify individual cells with
high DNA copy numbers. One million 3A cells were
transfected with HPV-16 genomic DNA and at various
times posttransfection, 104 cells were applied to a nylon
embrane, lysed, and probed for HPV-16 DNA. The re-
ults (Fig. 1A) show that the HPV-positive signal and
opy number in the 3A cells increase to day 15, become
lightly reduced at day 21, and decline thereafter. As can
e seen, there appears to be a number of high signal
pots at day 15. CaSki cells (1 3 103), used as positive
controls, contain about 600 copies of HPV-16 (Baker et
al., 1987) and the strong spots seen are likely due to cell
clumping. The appearance of a limited number of strong
individual spots suggests that high-level HPV-16 replica-
tion is limited to a only a subset of the 3A cells.
The HPV-16 replication levels were then analyzed in
another, more exhaustive, time course experiment by
Southern blot, shown in Fig. 1B. Again, 1 mg of HPV-16
reconstituted genomic DNA was transfected into a se-
ries of identical 3A cultures. The cells were fed every 3
days and total cellular DNA was harvested at the indi-
cated times. The DNA was digested with DpnI, to remove
input bacterial DNA, and BamHI, to drive all of the
HPV-16 DNA into one size. The DNA was then size-
separated, Southern blotted, and probed for HPV-16
DNA. As seen, a significant 8-kb band is visible in many
of the lanes, suggesting that the HPV-16 DNA is likely to
be present episomally. The DNA levels rise (replication)
significantly on day 9, increase further on day 12, plateau
until day 24, and then steadily decline afterward. In the
early stages, significant DNA levels are not seen until
day 9 and increase to the maximum at day 12. It is
interesting to note that these are roughly the same time
kinetics for HPV-16 replication in the organotypic epithe-
lial raft culture system, the only other tissue culture
system known to be fully productive for HPV (Meyers,
1996). There was no significant observable change in the
morphology of the cells after transfection or during the
complete course of the experiment. The presence of a
strong 8-kb band in these specimens is consistent with
episomal HPV-16 genomes or, less likely, head-to-tail
integrated concatemers. To more clearly indicate that the
majority of the DNA was episomal, we analyzed theHPV-16 DNA without digestion and with multiple zero-cut
restriction enzymes. Finally, the basic structure of the
replicated HPV-16 genome was analyzed with multiple-
cut restriction enzymes. As shown in Fig. 1C, the appear-
ance of forms I, II, and III in undigested DNA and the
appropriate sized bands in the digested lanes indicates
that the viral genome is episomal and that no large
deletions or rearrangements were present.
Early and late HPV-16 gene expression in 3A
trophoblasts
Given that HPV-16 was replicating its DNA in the 3A
trophoblasts, next, mRNA expression was analyzed by
reverse transcription-PCR (RT-PCR) using DNase
FIG. 1. HPV-16 DNA replication in 3A trophoblasts. (A) Analysis by
infectious center assay. 3A trophoblasts, grown at 39.5°C, were trans-
fected with 1 mg of recircularized HPV-16 genomic DNA at day 0. At the
ndicated times, cells were applied to membranes and analyzed by
ybridization for HPV-16 sequences. Note positive signals at days 9–24.
B) Analysis by Southern blot assay. Cells were treated as above except
hat 20 mg of the total cellular DNA was analyzed by Southern blot for
PV-16 sequences. Note high positive signals at days 9–24. The
arker lane was 0.5 ng of pHPV-16 plasmid cut with BamHI. (C)
nother analysis by Southern blot assay. This experiment was similar
o B, with harvesting at day 14 and digestion with the indicated restric-
ion enzymes. Note that DNA forms I, II, and III are seen in the
ndigested lane and appropriate sized fragments are seen in the
coRI, NdeI, and PstI digested lanes. EcoRI digestion results in frag-
ents of 7268 and 635 bases. NdeI digestion results in fragments of
847, 1825, 1357, 1225, 635, and 15 bases. PstI digestion results in
ragments of 2817, 1776, 1549, 1063, 483, and 216 bases.I-treated, poly(A) selected RNA as a template. E6, E2, and
























































101LIFE CYCLE OF HPV TYPE 16 IN PLACENTAL TROPHOBLASTStential of “early” and “late” gene expression. Also in-
cluded was a primer set for TFIIB as a constitutive cel-
ular control. After RT-PCR amplification, the products
ere analyzed by agarose gel electrophoresis and
thidium bromide staining. The results for E6 oncopro-
ein mRNA expression, shown in Fig. 2, E6, demonstrate
hat significant E6 expression does not take place until
ay 9 and then slowly declines. The expression of E2
ranscription factor mRNA was similar (Fig. 2, E2) and
ollows that of the HPV-16 DNA replication. Next, the
xpression of L1 capsid mRNA was analyzed, as shown
n Fig. 2, L1. As can be seen, the expression of significant
1 mRNA levels does not take place until day 18, 9 days
ater than E2 and E6. Thus, this late gene of HPV in skin
FIG. 2. HPV-16 RNA expression in 3A trophoblasts. (E6) E6 mRNA
xpression. E6 mRNA [poly(A)selected] was analyzed by RT-PCR as
escribed under Materials and Methods. Note that the expression of
FIIB is relatively stable over the time course while significant E6 RNA
xpression starts at day 9 and then declines thereafter. “1” refers to the
CR products generated from both the TFIIB and E6 primer sets using
he TFIIB and pAT-HPV-16 cloned DNAs as templates. “2” refers to the
RT-PCR products generated from both the TFIIB and E6 primer sets
using mRNA from untransfected 3A cells as a template. (E2) E2 mRNA
expression. E2 mRNA was analyzed by RT-PCR as described under
Materials and Methods. Note that E2 expression is like that of E6,
starting at day 9 and then declining. (L1) L1 mRNA expression. L1
mRNA was analyzed by RT-PCR as described under Materials and
Methods. Note that L1 mRNA expression is different than that of E6 or
E2, starting at day 18 and then declining. The small blip of early L1
expression was reproducible but much lower than expression at later
times. The mRNA samples were also analyzed by direct PCR and failed
to generate products (data not shown).s expressed late relative to the early genes in tropho-
lasts. The early low-level expression of L1 on days 3nd 6 was a reproducible event. As L1 mRNA was ex-
ressed at day 18, we further analyzed for L1 protein
xpression by Western blot analysis. Again, 3A cells
ere transfected with HPV-16 DNA and harvested at
ays 9 and 18. Total proteins were isolated, Western
lotted, and probed with anti-HPV-16 L1 monoclonal an-
ibody. The results are shown in Fig. 3 and demonstrate
hat L1 protein is expressed at day 18, but not at day 9,
onsistent with the mRNA findings.
roduction of HPV-16 infectious units in 3A
rophoblasts
The strong mRNA and protein expression of L1 on day
8 suggested the possibility that HPV-16 progeny virions
ere being produced at this time. Production of the L1
rotein leads to self-assembly of pseudo-particles even
n the absence of DNA (Kirnbauer et al., 1992; Muller et
l., 1997). To analyze whether HPV-16 virions were being
roduced, we generated putative virus stocks from HPV-
6-transfected trophoblast cultures at day 18 (L1 expres-
ion) and day 9 (no L1). The trophoblasts were lysed to
enerate a putative virus stock, which was then used to
nfect normal primary keratinocytes. The keratinocytes
ere then seeded onto collagen rafts containing J2 fibro-
lasts and then raised to the air to stimulate the forma-
ion of a stratified squamous epithelium that would be
avorable for HPV replication (the organotypic epithelial
aft culture system) (Meyers, 1996). The experiment is
chematically described in Fig. 4A. In this experiment
ny HPV-16 virions produced in the trophoblasts would
nfect the keratinocytes and be amplified in the raft “skin”
y day 12. At day 12 total raft DNA was isolated and
nalyzed for HPV-16 sequences by Southern blot. The
esults, shown in Fig. 4B, give no evidence of HPV-16
nfection and replication resulting from the day 9 lysate
RILT, rafts infected with lysed trophoblasts), while the
afts infected with the day 18 lysates show a strong 8-kb
FIG. 3. Production of L1 capsid protein by HPV-16 in trophoblasts.
Cells were treated as in Fig. 2 except that total proteins were isolated
at days 9 and 18 and analyzed for L1 protein. Western blot, using
anti-HPV-16 L1 monoclonal antibody and peroxidase-labeled second-
ary antibody. Note that no L1 protein was expressed in untransfected
cells or transfected cells harvested at day 9. In contrast, the cells
transfected and harvested at day 18 show a strong band at the size














102 LIU ET AL.band upon BamHI digestion. These data are consistent
with HPV-16 virion production on day 18.
To further support the notion that HPV-16 generated
infectious virions in trophoblasts, an antibody neutraliza-
tion experiment was undertaken using a series of well-
characterized antibodies. The HPV-16 virus stocks/lysed
trophoblasts were mixed with H16.V5 (HPV-16 neutraliz-
ing antibody), H16.J4 (HPV-16 nonneutralizing antibody),
HPV-18.J4 (HPV-18 neutralizing antibody), and H11.H3
(HPV-11 neutralizing antibody) (Roden et al., 1997; Chris-
tensen et al., 1996). Finally, H16.V5 was also treated with
.2 M b-mercaptoethanol (b-ME) before it was also
mixed with the HPV-16 virus stock. The infections were
4-h incubations, after which the keratinocytes were
transferred on top of the collagen matrixes and the ex-
periment was allowed to proceed as in Fig. 4. The results
(Fig. 5) show that only the antibody H16.V5, known to
FIG. 4. Production of HPV-16 virions in the trophoblasts. The generation
of HPV-16 virions was measured by the ability of trophoblast lysates to
infect normal keratinocytes, which were then placed into an organotypic
raft culture system to generate a stratified squamous epithelium product
for HPV. (A) The experimental scheme for showing infectious virus pro-
duction is diagramatically presented. (B) As in Figs. 1 and 2, 3A tropho-
blasts were mock or HPV-16 DNA lipofected, and at the indicated times a
putative virus stock was generated by freeze–thawing the cells. The virus
stocks were used to infect normal primary keratinocytes, which were then
introduced in the organotypic epithelial raft culture system. At 12 days
postinfection, total DNA was isolated from the rafts and analyzed by
Southern blot for HPV-16 sequences. Note that the mock and day 9 lysates
did not produce any evidence of HPV-16 infection, while the day 18 lysate
showed a significant 8-kb HPV-16-specific band.neutralize HPV-16, had a neutralizing effect on the
HPV-16 virus stock/trophoblast lysate, while all other
santibodies did not. Furthermore, treatment of H16.V5 with
b-ME inhibited this neutralization.
To further indicate that HPV-16 generated infectious
virions in trophoblasts, an analysis of E6‘E7 and E1‘E4
pliced transcripts in the initial HPV-16 lipofected 3A
ells and in secondary RILT was undertaken. The results
re shown in Fig. 6. Both transcripts were present in both
he initial 3A culture and the secondary RILT cells. How-
ver, observation of the E6‘E7 transcript in RILT required
FIG. 5. Specific antibody neutralization of HPV-16 virions produced in
trophoblasts. This experiment was similar to Fig. 4, except that the
HPV-16 virus stocks were pretreated with the indicated antibodies
before the keratinocytes were infected. In addition, H16.V5 was also
treated with b-ME. The marker lane was 0.5 ng of pHPV-16 plasmid cut
with BamHI. Note that only untreated H16.V5, known to neutralize
HPV-16, was able to prevent the infection of the raft tissue.
FIG. 6. HPV-16 E6‘E7 and E1‘E4 spliced transcripts are present in
ILT-16 as analyzed by RT-PCR. Details are presented under Materials and
ethods. Briefly, 3A trophoblasts were transfected with HPV-16 DNA as in
ig. 1. At day 21 some initial 3A cells were used for poly(A) RNA isolation,
hile others were lysed and used to generate a virus stock as in Fig. 4.
oly(A) RNA was also isolated from day 12 keratinocyte rafts infected with
rophoblast lysates (RILT) and analyzed by RT-PCR. Mock-lipofected 3A
ells and mock-infected RILT were included as controls. Note that the
6‘E7 and E1‘E4 transcripts were present in both the original 3A and
econdary RILT. The E6‘E7 transcripts in the RILT required nested PCR to






























































103LIFE CYCLE OF HPV TYPE 16 IN PLACENTAL TROPHOBLASTSa second, nested PCR amplification. These data provide
a third set of evidence, in addition to the temporal ap-
pearance of infectious units (Fig. 4) and the neutraliza-
tion of infectious units with specific antibodies (Fig. 5), all
consistent with the production of infectious HPV-16 viri-
ons in trophoblasts.
DISCUSSION
This study demonstrates that HPV-16 is fully active in
trophoblasts. HPVs are already well known to be patho-
genic viruses and are the largest risk factor in the de-
velopment of cervical cancer (Melbye and Frisch, 1998).
Thus, 3A trophoblasts may represent a new host cell
type, in addition to the well-studied replication of HPVs in
differentiating keratinocytes. These data also support the
hypothesis that HPV infection of trophoblasts may be
linked to some spontaneous abortions. The search for
factors that may be implicated in spontaneous abortion
has led to the examination of numerous factors, includ-
ing maternal age, environmental exposures, tobacco
use, and nutritional factors (Barrington et al., 1996;
ordier et al., 1991; Coste et al., 1991; Dominguez et al.,
991; Kline et al., 1995; Neuqebauer et al., 1996; Parazzini
t al., 1991; Risch et al., 1988; Stucker et al., 1990; Tan et
l., 1995). However, the studies exploring these relation-
hips have been inconsistent in their findings. For every
tudy supporting an association with spontaneous abor-
ions, there is another study that does not support a
elationship. The only uncontested factor, thus far, is
aternal age. However, two studies place HPVs in 60–
0% of spontaneous abortions (Hermonat et al., 1997;
alhomme et al., 1997). Furthermore, preliminary data
uggest that HPV-11 and HPV-18 are also able to repli-
ate in 3A trophoblasts (You, Liu, and Hermonat, unpub-
ished results). If these miscarriages are, in fact, due to
PV infection, then the number of resulting human ges-
ational fatalities may be large, possibly numbering in the
illions in the United States per year. If the link between
PV infection and gestational loss can be further sub-
tantiated, then specific treatment protocols might be
eveloped.
Replication levels of HPV-16 peak at days 15–27 and
hen start to decline. What is responsible for this decline
s unclear. Possibly this is due to the death of the cells
hat are productive for HPV, but further experiments are
eeded to determine whether this is the correct interpre-
ation. Finally, these data represent a technological ad-
ance in the ease of studying HPV over the tedious and
xpensive organotypic raft culture system.
MATERIALS AND METHODS
nfectious center and Southern blot analyses of
eplicationThe infectious center technique was carried out in a
anner similar to that described previously (Schlehofert al., 1983). Briefly, 3A trophoblasts (ATCC CRL1583)
ere grown at 39.5–40°C in Dulbecco’s modified Eagle’s
edium with 7% fetal bovine serum. Reconstituted
PV-16 genomic DNA was generated by cutting the
PV-16 sequences from the cloned HPV-16 plasmid
pAT-HPV-16) (Bubb et al., 1988) with BamHI, followed by
ligation and recircularization. For infectious center anal-
ysis, 1 3 106 3A cells were transfected with 1 mg of
HPV-16 genomic DNA using FuGENE 6 (Roche Diagnos-
tics Corp.). At the indicated times postlipofection the 3A
cells were trypsinized and 1 3 104 cells were applied to
and lysed on nylon membranes under continuous suc-
tion. The membranes were then probed with 32P-labeled
PV-16 DNA. For Southern blot analysis of HPV-16 infec-
ion, 1 3 106 3A cells were transfected with 1 mg HPV-16
enomic DNA and harvested at the indicated times (days
–45). Twenty micrograms of the total cellular DNA from
ach time was digested by both DpnI and BamHI, aga-
rose gel electrophoresed, Southern blotted, and probed
with 32P-labeled HPV-16 DNA.
RNA isolation and RT-PCR analysis of unspliced and
pliced transcripts
HPV-16 mRNA expression was measured by RT-PCR
long with a cellular mRNA control. 3A cells were lipo-
ected at day 0 and total RNA was isolated at the indi-
ated days using Trizol reagent (Gibco BRL Life Technol-
gies Inc.), according to the manufacturer’s protocol, and
reated with 5 U/mg of RNase-free DNase I (Promega
Co.) at 37°C for 2 h. Messenger RNA was then separated
using the Oligotex mRNA Mini Kit (Qiagen Inc.) according
to the supplier’s instructions. The first-strand cDNA syn-
thesis was performed at 37°C for 1 h in a final volume of
25 ml reaction buffer [1 mg mRNA; 50 mM Tris–HCl, pH
8.3; 75 mM KCl; 3 mM MgCl2; 10 mM DTT; 0.5 mg
ligo(dT)15 (Promega Co.); 0.5 mM each of the four
dNTPs; 30 U of RNasin (Promega Co.); and 200 U of
M-MLV Reverse Transcriptase RNase H Minus (Promega
Co.)]. PCR amplification of the cDNA was performed in a
100-ml reaction volume that contained 2.5 U Taq DNA
olymerase (Fisher Scientific Co.); 10 mM Tris–HCl, pH
.3; 50 mM KCl; 2 mM MgCl2; 0.2 mM each of the four
NTPs; a 1 mM concentration of each upstream and
ownstream primer specific for the cDNA template; and
0 ml cDNA template. The E6 primer set used was 59-
CCACAGTTATGCACAGAGC-39 and 5-AGGACACAGTG-
CTTTTGAC-39, which targeted amplification of the
PV-16 sequences from nt 139 to 420. The E2 primer set
sed was 59-AACACAGACGACTATCCAGC-39 and 59-AT-
CCATGTAGACGACACTG-39, which targeted amplifica-
ion from nt 3454 to 3696. The L1 primer set used was
-GCACAGGGCCACAATAATGG-39 and 59-CGTCCTA-
AAGGAAACTGATC-39, which targeted amplified from nt
6583 to 7033. The expected product sizes for E6, E2, and


































104 LIU ET AL.control RT-PCR analysis of expression of the houskeep-
ing gene TFIIB (Ha et al., 1991) was also undertaken with
the primer set 59-GTGAAGATGGCGTCTACCAG-39 and
59-GCCTCAATTTATAGCTGTGG-39, which amplified nt
356–1314 of that mRNA. Several controls were also un-
dertaken. First, a direct PCR was undertaken (data not
shown) to observe any contaminating DNA. Second, a
negative-control RT-PCR was undertaken using mRNA
isolated from untransfected 3A cells. Third, a positive-
control PCR was undertaken to observe correct product
sizes using DNA as a template. The products were then
analyzed on an agarose gel, stained with ethidium bro-
mide, and visualized by ultraviolet light.
To measure the HPV-16 spliced mRNA, RT-PCRs were
performed on poly(A) RNA isolated from 3A cells and
normal keratinocyte rafts infected with trophoblast ly-
sates using three additional HPV-16 primers sets. One,
previously described by White et al. (1998), was designed
to observe E1‘E4 transcripts. Two, previously described
by Sotlar et al. (1998), were nested and designed to
observe E6‘E7 transcripts. The E1‘E4 primer set used
as 59-TGGAGAACCTGTTAATGGGCACAC-39 (located at
ases 797 to 818 in the HPV-16 genomic sequence) and
9-TATAGACATAAATCCAGTAGACAC-39 (located at bases
826 to 3849 in the HPV-16 genomic sequence). Two of
he E6‘E7 primer sets used were as follows: A, 59-
CAGTTATGCACAGAGCTGC-39 (located at bases 142 to
61 in the HPV-16 genomic sequence) and 59-CTCC TC
TCTGAGCTGTCAT-39 (located at bases 647 to 666 in
he HPV-16 genomic sequence); and B, 59-GTGTGTACT-
CAAGCAACAG-39 (located at bases 192 to 211 in the
PV-16 genomic sequence) and 59-GCAATGTAGGTG-
ATCTCC-39 (located at bases 568 to 586 in the HPV-16
enomic sequence). The expected lengths of the E1‘E4,
6‘E7A, and E6‘E7B RT-PCR products are 510, 525, and
95 bp, respectively. To analyze spliced transcripts in 3A
ells RT-PCRs were carried out with the E1‘E4 primer set
and E6‘E7 primer set A. To analyze spliced transcripts in
ysate infected rafts, E1‘E4 was analyzed as in the 3A
ells. However, observation of E6‘E7 transcripts re-
quired nested PCR using sequentially set A and then set
B. To ensure that DNA was not contributing to the results,
a direct PCR was also undertaken.
Western blot analysis
Expression of L1 capsid protein by HPV-16 was mea-
sured by Western blot. 3A cells were lipofected with
HPV-16 as before, except that total proteins were iso-
lated at days 9 and 18 and analyzed for L1 protein.
Western blot was done according to routine protocol.
After the electrophoresis and transfer, the nitrocellulose
membrane (Amersham Life Science Co.) was treated
with blocking buffer (The Protein Detector Western Blot
Kit, Kirkegaard & Perry Laboratories, Inc.) for 1 h. Purified
mouse anti-human HPV-16 L1 monoclonal antibody(mouse IgG2a, PharMingen International) was added to
the buffer (1.5 mg/ml). The membrane was incubated at
4°C overnight and then washed with washing buffer (The
Protein Detector Western Blot Kit) five times. The mem-
brane was put into 13 blocking buffer containing perox-
idase-labeled secondary antibody [goat anti-mouse IgG
(H 1 L), 1:1000, the Protein Detector Western Blot Kit]
nd incubated at room temperature for 1 h. After the
embrane was washed six times, TMB substrate (The
rotein Detector Western Blot Kit) was applied. The re-
ction was stopped when the suitable color intensity
as observed.
nfectious virion and antibody neutralization analysis
The generation of infectious HPV-16 virions in tropho-
lasts was measured by the ability of trophoblast lysates
o infect normal keratinocytes (Clonetics Inc.), which
ere then placed into an organotypic raft culture system
o generate a stratified squamous epithelium product for
PV. “RILT-16” is an abbreviation for “rafts infected with
ysed trophoblasts that had been transfected with HPV-
6.” 3A trophoblasts were mock or HPV-16 lipofected (1
mg), and then at the indicated times the cells were
freeze–thawed three times to lyse the cells, and the
lysate was filtered (0.22-mm filter) and treated with 100
nits/ml DNase for 1 h. The generated putative virus
tocks were then used to infect 5 3 106 primary keratin-
ocytes (Clonetics, Inc.), for 4 h. These cells were then
trypsinized and seeded onto collagen rafts containing J2
fibroblasts as described by Meyers (1996) to generate an
organotypic epithelial raft culture system. HPVs are
known to productively replicate in this system. Twelve
days after the raft was raised to the air interface, suffi-
cient time to allow for HPV replication, the raft tissues
were harvested, and total cellular DNA was isolated,
agarose gel electrophoresed, Southern blotted, and
probed with 32P-labeled HPV-16 DNA. HPV-16 virion pro-
duction was further verified by specific antibody neutral-
ization. This experiment was similar to that described
above, except that the HPV-16 virus stocks were pre-
treated with the indicated antibodies, diluted 1/1000,
before the keratinocytes were infected. In addition, the
antibody H16.V5 was pretreated with 200 mM b-ME.
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